Methylarsenicals and Arsinothiols Are Potent Inhibitors of Mouse Liver Thioredoxin Reductase
- 9 September 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 12 (10) , 924-930
- https://doi.org/10.1021/tx9900775
Abstract
Thioredoxin reductase (TR, EC 1.6.4.5) was purified 5800-fold from the livers of adult male B6C3F1 mice. The estimated molecular mass of the purified protein was about 57 kDa. The activity of the purified enzyme was monitored by the NADPH-dependent reduction of 5,5‘-dithiobis(2-nitrobenzoic acid) (DTNB); this activity was fully inhibited by 1 μM aurothioglucose. Arsenicals and arsinothiols, complexes of AsIII-containing compounds with l-cysteine or glutathione, were tested as inhibitors of the DTNB reductase activity of the purified enzyme. Pentavalent arsenicals were much less potent inhibitors than trivalent arsenicals. Among all the arsenicals, CH3AsIII was the most potent inhibitor of TR. CH3AsIII was found to be a competitive inhibitor of the reduction of DTNB (Ki ∼ 100 nM) and a noncompetitive inhibitor of the oxidation of NADPH. The inhibition of TR by CH3AsIII was time-dependent and could not be reversed by the addition of a dithiol-containing molecule, 2,3-dimercaptosuccinic acid, to the reaction mixture. The inhibition of TR by CH3AsIII required the simultaneous presence of NADPH in the reaction mixture. However, unlike other pyridine nucleotide disulfide oxidoreductases, there was no evidence that mouse liver TR was inactivated by exposure to NADPH. Treatment with CH3AsIII did not increase the NADPH oxidase activity of the purified enzyme. Thus, CH3AsIII, a putative intermediate in the pathway for the biomethylation of As, is a potent and irreversible inhibitor of an enzyme involved in the response of the cell to oxidative stress.Keywords
This publication has 20 references indexed in Scilit:
- Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cellsJournal of Biochemical and Biophysical Methods, 1998
- A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductaseBiochemical Journal, 1998
- The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coliProceedings of the National Academy of Sciences, 1997
- ENZYMATIC METHYLATION OF ARSENIC SPECIES AND OTHER NEW APPROACHES TO ARSENIC TOXICITYAnnual Review of Pharmacology and Toxicology, 1997
- Comparative Inhibition of Yeast Glutathione Reductase by Arsenicals and ArsenothiolsChemical Research in Toxicology, 1997
- Time dependence of accumulation and binding of inorganic and organic arsenic species in rabbit erythrocytesChemico-Biological Interactions, 1995
- Human Thioredoxin Reductase Directly Reduces Lipid Hydroperoxides by NADPH and Selenocystine Strongly Stimulates the Reaction via Catalytically Generated SelenolsJournal of Biological Chemistry, 1995
- A chemical hypothesis for arsenic methylation in mammalsChemico-Biological Interactions, 1993
- Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non‐stoichiometric oxidation of NADPH in the presence of oxygenEuropean Journal of Biochemistry, 1992
- THIOREDOXINAnnual Review of Biochemistry, 1985